ESSA Pharma Inc.

NASDAQ: EPIX · Real-Time Price · USD
1.93
0.01 (0.52%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.00%
After-hours: Aug 15, 2025, 07:33 PM EDT

ESSA Pharma Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
24.04K n/a n/a 22.66K 15.5K 29.71K 27.15K 30.45K 30.45K 30.45K 30.45K 30.45K 30.45K 30.45K 28.8K 25.5K 27.58K n/a
Gross Profit
-24.04K n/a n/a -22.66K -15.5K -29.71K -27.15K -30.45K -30.45K -30.45K -30.45K -30.45K -30.45K -30.45K -28.8K -25.5K -27.58K n/a
Operating Income
-7.38M -9.92M -1.82M -8.64M -10.49M -5.38M -5.48M -6.27M -7.09M -6.75M -6.42M -8.77M -10.92M -9.09M -9.22M -9.35M -11.88M -6.69M
Interest Income
1.01M n/a n/a n/a n/a 1.64M 1.67M 1.61M 1.16M 1.11M 762.43K 417.87K 481.75K 74.58K 79.7K 80.39K 39.21K 35.69K
Pretax Income
-6.37M -8.53M -6.36M -7.23M -8.99M -5.96M -5.48M -7.3M -7.06M -6.74M -6.39M -8.87M -10.85M -9.1M -8.56M -8.75M -12.97M -6.56M
Net Income
-6.37M -8.53M -6.36M -7.23M -8.99M -5.96M -5.48M -7.3M -7.06M -6.73M -6.32M -8.83M -10.79M -9.1M -8.56M -8.75M -12.97M -6.53M
Selling & General & Admin
3.87M 4.44M 3.75M 3.17M 4.3M 2.42M 2.09M 2.81M 3.73M 2.58M 2.77M 2.76M 3.72M 3.03M 2.91M 3.09M 4.59M 2.21M
Research & Development
3.48M 5.47M 4.19M 5.46M 6.18M 5.38M 5.23M 6.27M 4.48M 5.34M 4.35M 6.39M 7.65M 6.02M 6.27M 6.23M 7.27M 4.49M
Other Expenses
n/a n/a -917.42K n/a n/a n/a 63.78K n/a n/a -63.78K n/a 135.72K 95.5K 30.45K 28.8K 25.5K 27.58K 43K
Operating Expenses
7.36M 9.66M 7.02M 8.64M 10.48M 7.59M 7.15M 8.91M 8.21M 7.86M 7.12M 9.29M 11.47M 9.08M 9.22M 9.35M 11.88M 6.7M
Interest Expense
n/a n/a n/a n/a n/a n/a 1.12K 1.53K 1.94K 2.35K 3K 3.15K 3.53K 4.33K 4.07K 16.67K 299.00 1K
Selling & Marketing Expenses
n/a n/a n/a 33.59K -236.13K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.38M 9.92M 7.02M 8.64M 10.49M 7.59M 7.15M 8.91M 8.21M 7.86M 7.12M 9.29M 11.47M 9.08M 9.22M 9.35M 11.88M 6.7M
Income Tax Expense
n/a n/a 20.27K n/a -5 -20.27K 1.12K 1.53K 2K -11.53K -66K -45.77K -68.94K 100.00 4.07K 800.00 299.00 -35K
Shares Outstanding (Basic)
44.39M 44.37M 44.37M 44.37M 44.24M 44.13M 44.1M 44.09M 44.09M 44.07M 44.07M 44.06M 44.03M 43.99M 41.02M 41.02M 36.48M 33.34M
Shares Outstanding (Diluted)
44.39M 44.37M 44.37M 44.37M 44.24M 44.13M 44.1M 44.09M 44.09M 44.07M 44.07M 44.06M 44.03M 43.99M 41.02M 41.02M 36.48M 33.34M
EPS (Basic)
-0.14 -0.19 -0.14 -0.16 -0.2 -0.14 -0.12 -0.17 -0.16 -0.15 -0.14 -0.2 -0.24 -0.21 -0.21 -0.21 -0.36 -0.2
EPS (Diluted)
-0.14 -0.19 -0.14 -0.16 -0.2 -0.14 -0.12 -0.17 -0.16 -0.15 -0.14 -0.2 -0.24 -0.21 -0.21 -0.21 -0.36 -0.2
EBITDA
-6.35M -8.51M -6.33M -7.21M -8.97M -5.93M -5.45M -7.27M -7.03M -6.71M -6.36M -8.84M -10.82M -9.06M -8.53M -8.71M -12.94M -6.54M
EBIT
-6.37M -9.92M -6.36M -7.23M -8.99M -5.96M -5.48M -7.3M -7.06M -6.74M -6.39M -8.87M -10.85M -9.09M -8.56M -8.73M -12.96M -6.56M
Depreciation & Amortization
24.04K 1.41M -67.88K 22.66K 15.5K 29.71K 27.15K 30.45K 30.45K 30.45K 30.45K 30.45K 30.45K 30.45K 28.8K 25.5K 27.58K 27.58K